In fiscal 2025, which ended Sep 30, 2025, cbdMD, Inc. used $1.5 million of cash from operations, down 311.7% from the year before. It spent $184,172 on capital expenditures. Free cash flow was negative, at -$1.6 million.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Sep 30, 2025
|
FY 2024
Sep 30, 2024
|
FY 2023
Sep 30, 2023
|
FY 2022
Sep 30, 2022
|
FY 2021
Sep 30, 2021
|
FY 2020
Sep 30, 2020
|
FY 2019
Sep 30, 2019
|
FY 2018
Sep 30, 2018
|
FY 2017
Sep 30, 2017
|
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||
| Depreciation and amortization |
0
-46.4%
|
0
-20.2%
|
0
+11.9%
|
0
-57.4%
|
1
-6.7%
|
1
+41.2%
|
1
+148.9%
|
0
+30.1%
|
0
+212.2%
|
0
|
| Stock-based compensation |
—
|
—
|
—
|
—
|
—
|
1
-31.7%
|
2
-22.7%
|
2
+284.4%
|
1
+1031.4%
|
0
|
| Operating cash flow |
-2
-112.4%
|
-1
-311.7%
|
-0
+91.8%
|
-4
+71.3%
|
-15
-6.2%
|
-14
-32.2%
|
-11
+30.6%
|
-15
-175.9%
|
-6
-139.2%
|
-2
|
| Investing | ||||||||||
| Capital expenditures |
0
+0.0%
|
0
-3.1%
|
0
-36.1%
|
0
-56.8%
|
1
+101.4%
|
0
-74.1%
|
1
+10.1%
|
1
+4987.7%
|
0
+195.7%
|
0
|
| Investing cash flow |
-0
+53.7%
|
-0
+36.5%
|
-0
-141.3%
|
1
+202.0%
|
-1
+73.0%
|
-3
-62.5%
|
-2
+26.4%
|
-2
-212.2%
|
-1
-456.0%
|
0
|
| Financing | ||||||||||
| Dividends paid |
—
|
—
|
—
|
—
|
—
|
3
+596.4%
|
0
|
—
|
—
|
—
|
| Financing cash flow |
3
+341164200.0%
|
1
+11.4%
|
1
+198.1%
|
-1
+67.2%
|
-4
-114.3%
|
28
+26.2%
|
22
+24.8%
|
18
+74.7%
|
10
+329.5%
|
2
|
| Change in cash | ||||||||||
| Free cash flow |
-2
-95.0%
|
-2
-201.5%
|
-1
+88.2%
|
-5
+70.6%
|
-16
-8.5%
|
-14
-20.5%
|
-12
+27.7%
|
-17
-196.2%
|
-6
-139.4%
|
-2
|
| Per share | ||||||||||
| Free cash flow per share |
—
|
-0.41
+59.6%
|
-1.01
+55.7%
|
-2.27
+80.7%
|
-11.79
-4387.4%
|
-0.26
+1.0%
|
-0.27
+71.4%
|
-0.93
|
—
|
—
|
| Shareholder returns | ||||||||||
| Returned to shareholders |
—
|
—
|
—
|
—
|
—
|
3
|
0
|
—
|
—
|
—
|
| Ratios | ||||||||||
| Free cash flow margin |
-11.51%
|
-8.53%
|
-2.72%
|
-18.36%
|
-42.17%
|
-32.45%
|
-28.61%
|
-70.08%
|
-1,219.07%
|
-52.24%
|
| Capital expenditures to revenue |
0.91%
|
0.96%
|
0.95%
|
1.19%
|
1.86%
|
0.77%
|
3.15%
|
5.07%
|
5.13%
|
0.18%
|
| Stock-based compensation to revenue |
—
|
—
|
—
|
—
|
—
|
2.92%
|
4.54%
|
10.39%
|
139.33%
|
1.26%
|
| Cash conversion |
—
|
—
|
—
|
—
|
—
|
—
|
-0.85x
|
—
|
-88.70x
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
- Listed as
- YCBD (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- NC
- Headquarters
- Charlotte, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1644903
- Former names
- Level Brands, Inc. (until May 1, 2019); LEVEL BEAUTY GROUP, INC. (until Sep 27, 2016)
Other Perfumes, Cosmetics & Other Toilet Preparations companies
- Colgate Palmolive Co CL
- Haleon plc HLN
- Estee Lauder Companies Inc EL
- e.l.f. Beauty, Inc. ELF
- Interparfums Inc IPAR
- Coty Inc. COTY
- EDGEWELL PERSONAL CARE Co EPC
- Oddity Tech Ltd ODD
All 22 Perfumes, Cosmetics & Other Toilet Preparations companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.